Sign in
Explore the registryTrack Olezarsen's trials

CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)

OlezarsenOngoingActive not recruitingPhase 3Open NCT05681351 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…